Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Importance of Survivin in Stem Cells and Cancer: the Development of New Cancer Therapeutics
Neerada Meenakshi Warrier, Prasoon Agarwal, Praveen Kumar
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 5, pp. 828-852
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 75
Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy
Aishwarya Saraswat, Hari Priya Vemana, Vikas V. Dukhande, et al.
Heliyon (2022) Vol. 8, Iss. 1, pp. e08702-e08702
Open Access | Times Cited: 47
Survivin Small Molecules Inhibitors: Recent Advances and Challenges
Najah Albadari, Wěi Li
Molecules (2023) Vol. 28, Iss. 3, pp. 1376-1376
Open Access | Times Cited: 36
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 30
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
Claudia Galassi, Martina Musella, Nicoletta Manduca, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2361-2361
Open Access | Times Cited: 53
Cancer Stem Cells in Ovarian Cancer—A Source of Tumor Success and a Challenging Target for Novel Therapies
Jacek R. Wilczyński, Miłosz Wilczyński, Edyta Paradowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2496-2496
Open Access | Times Cited: 35
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 29
Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target
Xianlong Fang, Xue-ping Cao, Jun Xiao, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 223-240
Closed Access | Times Cited: 5
Survivin in Breast Cancer: A Review
Manuel Antonio Martínez-Sifuentes, Susana Bassol‐Mayagoitia, Martha P. Nava-Hernández, et al.
Genetic Testing and Molecular Biomarkers (2022) Vol. 26, Iss. 9, pp. 411-421
Closed Access | Times Cited: 25
Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
Yaoquan Cao, Haibo Tang, Guohui Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development
Sree Karani Kondapuram, Hema Kasthuri Ramachandran, Hemant Arya, et al.
Life Sciences (2023) Vol. 335, pp. 122260-122260
Closed Access | Times Cited: 10
Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents
Qing Zhou, Xiotian Sun, Nicolas Pasquier, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2504-2504
Open Access | Times Cited: 26
Stem cells for the treatment of glioblastoma: a 20-year perspective
Anda‐Alexandra Calinescu, McKenzie C. Kauss, Zain Sultan, et al.
CNS Oncology (2021) Vol. 10, Iss. 2
Open Access | Times Cited: 25
Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance
Xin Dong, Wenbin Liu, M Kellis, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 17
Autophagy Process in Trophoblast Cells Invasion and Differentiation: Similitude and Differences With Cancer Cells
Lorena Carvajal, Jaime Gutiérrez, Eugenia Morselli, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 20
Bioinformatics analysis of BIRC5 in human cancers
Han-Bin Ye, Ma Baojun, Gao-Qiang Meng, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 888-888
Open Access | Times Cited: 15
The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions
Onyinye Ugonabo, Utibe-Abasi Udoh, Pradeep Rajan, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1369-1369
Open Access | Times Cited: 8
Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier
Aadya Nayak, Neerada Meenakshi Warrier, Rachana Raman, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 99, pp. 105980-105980
Open Access | Times Cited: 2
Starting points for the development of new targeted therapies for glioblastoma multiforme
Agnieszka Rusak, Benita Wiatrak, Klaudia Krawczyńska, et al.
Translational Oncology (2024) Vol. 51, pp. 102187-102187
Closed Access | Times Cited: 2
Aromatic monophenols from cinnamon bark act as proteasome inhibitors by upregulating ER stress, suppressing FoxM1 expression, and inducing apoptosis in prostate cancer cells
Srividya Gopalakrishnan, Ayesha Ismail
Phytotherapy Research (2021) Vol. 35, Iss. 10, pp. 5781-5794
Closed Access | Times Cited: 16
Survivin Inhibition by Piperine Sensitizes Glioblastoma Cancer Stem Cells and Leads to Better Drug Response
Neerada Meenakshi Warrier, Ramesh Kumar Krishnan, V.K. Prabhu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7604-7604
Open Access | Times Cited: 11
Contribution of survivin to the immune system, allergies and autoimmune diseases
Abdollah Jafarzadeh, Nasrin Bazargan, Nazanin Chatrabnous, et al.
Human Immunology (2023) Vol. 84, Iss. 4, pp. 301-310
Closed Access | Times Cited: 6
Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway
Xiaoying Li, Li Zhou, Ruike Wang, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 6
Closed Access | Times Cited: 6
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants
Demitria M. Vasilatis, Christopher A. Lucchesi, P. Ghosh
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1100-1100
Open Access | Times Cited: 5
Catalase-gold nanoaggregates manipulate the tumor microenvironment and enhance the effect of low-dose radiation therapy by reducing hypoxia
Alireza Najafi, Maryam Keykhaee, Mohammad Hossein Kazemi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115557-115557
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top